<DOC>
	<DOCNO>NCT00317226</DOCNO>
	<brief_summary>The primary objective study evaluate long term safety tolerability iron maintenance dose strategy utilize VIT45 treatment anemia non-dialysis dependent chronic kidney disease ( NDD-CKD ) . This study long term extension protocol 1VIT04004 ( NCT00317239 ) .</brief_summary>
	<brief_title>Long Term Safety Study ( VIT45 ) Extension Study : Treatment Anemia Non-Dialysis Dependent Chronic Kidney Disease</brief_title>
	<detailed_description>The primary objective study evaluate long term safety tolerability iron maintenance dose strategy utilize VIT45 treatment anemia non-dialysis dependent chronic kidney disease ( NDD-CKD ) . This study long term extension protocol 1VIT04004 . In study patient complete protocol 1VIT 04004 discontinue offer participate extension study .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Subjects complete discontinue Protocol 1VIT04004 Known hypersensitivity reaction VIT45 Anemia relate CKD Chronic , serious infection Recent IV iron study drug past 12 week Recent blood loss within last 12 week Need surgery dialysis Female subject pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Anemia</keyword>
	<keyword>CKD</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Iron</keyword>
	<keyword>Maintenance Dose</keyword>
</DOC>